These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 16362414)
21. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Dai Y; Qiao L; Chan KW; Yang M; Ye J; Ma J; Zou B; Gu Q; Wang J; Pang R; Lan HY; Wong BC Cancer Res; 2009 Jun; 69(11):4776-83. PubMed ID: 19458067 [TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer. Shigeto T; Yokoyama Y; Xin B; Mizunuma H Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343 [TBL] [Abstract][Full Text] [Related]
23. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. Yoshizumi T; Ohta T; Ninomiya I; Terada I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Yi S; Miwa K Int J Oncol; 2004 Sep; 25(3):631-9. PubMed ID: 15289864 [TBL] [Abstract][Full Text] [Related]
24. PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells. Schaefer KL; Takahashi H; Morales VM; Harris G; Barton S; Osawa E; Nakajima A; Saubermann LJ Int J Cancer; 2007 Feb; 120(3):702-13. PubMed ID: 17096328 [TBL] [Abstract][Full Text] [Related]
25. Latrunculin a has a strong anticancer effect in a peritoneal dissemination model of human gastric cancer in mice. Konishi H; Kikuchi S; Ochiai T; Ikoma H; Kubota T; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Sonoyama T; Kokuba Y; Sasaki H; Matsui T; Otsuji E Anticancer Res; 2009 Jun; 29(6):2091-7. PubMed ID: 19528469 [TBL] [Abstract][Full Text] [Related]
26. [Regulatory effects of peroxisome proliferator-activated receptor gamma on the growth of pancreatic carcinoma]. Dong YW; Wang XP; Wu K; Wu LY; Zhang RL Zhonghua Nei Ke Za Zhi; 2003 Jul; 42(7):479-82. PubMed ID: 12921608 [TBL] [Abstract][Full Text] [Related]
27. Reg IV enhances peritoneal metastasis in gastric carcinomas. Kuniyasu H; Oue N; Sasahira T; Yi L; Moriwaka Y; Shimomoto T; Fujii K; Ohmori H; Yasui W Cell Prolif; 2009 Feb; 42(1):110-21. PubMed ID: 19143768 [TBL] [Abstract][Full Text] [Related]
28. ZnPPIX inhibits peritoneal metastasis of gastric cancer via its antiangiogenic activity. Shang FT; Hui LL; An XS; Zhang XC; Guo SG; Kui Z Biomed Pharmacother; 2015 Apr; 71():240-6. PubMed ID: 25960243 [TBL] [Abstract][Full Text] [Related]
29. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy. Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197 [TBL] [Abstract][Full Text] [Related]
30. Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer. Ramachandran L; Manu KA; Shanmugam MK; Li F; Siveen KS; Vali S; Kapoor S; Abbasi T; Surana R; Smoot DT; Ashktorab H; Tan P; Ahn KS; Yap CW; Kumar AP; Sethi G J Biol Chem; 2012 Nov; 287(45):38028-40. PubMed ID: 22992727 [TBL] [Abstract][Full Text] [Related]
31. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway. Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692 [TBL] [Abstract][Full Text] [Related]
32. LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target. Kang X; Li W; Liu W; Liang H; Deng J; Wong CC; Zhao S; Kang W; To KF; Chiu PWY; Wang G; Yu J; Ng EKW Oncogene; 2021 May; 40(19):3422-3433. PubMed ID: 33883692 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292 [TBL] [Abstract][Full Text] [Related]
34. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253 [TBL] [Abstract][Full Text] [Related]
35. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer. Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357 [TBL] [Abstract][Full Text] [Related]
36. Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells. Nakahara C; Nakamura K; Yamanaka N; Baba E; Wada M; Matsunaga H; Noshiro H; Tanaka M; Morisaki T; Katano M Clin Cancer Res; 2003 Nov; 9(14):5409-16. PubMed ID: 14614027 [TBL] [Abstract][Full Text] [Related]
37. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver. Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice. Ohashi N; Kodera Y; Nakanishi H; Yokoyama H; Fujiwara M; Koike M; Hibi K; Nakao A; Tatematsu M Int J Oncol; 2005 Sep; 27(3):637-44. PubMed ID: 16077911 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of peritoneal metastasis in an animal gastric cancer model by interferon-gamma and interleukin-2. Okamoto T; Tsuburaya A; Yanoma S; Yoshikawa T; Cho H; Takanashi Y; Noguchi Y Anticancer Res; 2003; 23(1A):149-53. PubMed ID: 12680206 [TBL] [Abstract][Full Text] [Related]
40. Prostaglandin D synthase is a potential novel therapeutic agent for the treatment of gastric carcinomas expressing PPARγ. Fukuoka T; Yashiro M; Kinoshita H; Morisaki T; Hasegawa T; Hirakawa T; Aomatsu N; Takeda H; Maruyama T; Hirakawa K Int J Cancer; 2015 Sep; 137(5):1235-44. PubMed ID: 25516376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]